Tokyo, Oct. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063314) titled 'A Study on Early Stress and Inflammatory Dynamics for Predicting Outcomes in Immune Checkpoint Inhibitor Therapy' on Oct. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Toranomon Hospital
Condition:
Condition - Unresectable and Advanced Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigate whether chronic stress status and early inflammatory dynamics are associated with treatment response and prognosis in unresectable or advanced cancer patients undergoing immune checkpoint inhibitor therapy.
Basic objectives2 - Efficacy
Eligibilit...